1. Pharmaceutical supply chain risks: a systematic review;Jaberidoost;DARU J. Pharm. Sci.,2013
2. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use;Committee Report;Qual. Risk Manage.,2005
3. Gregg Claycamp, H., Ph.D. 2006., ICH Q9: Quality Risk Management, CDER Advisory Committee For Pharmaceutical Science (ACPS), October 5-6, 2006 Rockville, MD, Online access of PPT,gregg.claycamp@fda.hhs.gov (2-4). https://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4241s1_3.ppt.
4. Committee Report, PDA. 2013. Microbial risk in pharmaceutical manufacturing and ICH Q9, PDA J. Pharm. Sci. Technol. March/April 2013 (79-80). http://www.pharmamicroresources.com/2013/04/microbial-risk-in-pharmaceutical.html?m=1.
5. Maulik Chokshi Rahul Mongia Vasudha Wattal ICRIER Working Paper 310. Drug Quality and safety Issues in India Indian Counc. Res. Int. Econ. Relat. 2015 2-5 http://icrier.org/pdf/Working_Paper_310.pdf.